[Medical pharmacogenetics. I. Methods applied in pharmacogenetic studies].
D002395:Catecholamines / Q000009:adverse effects; D005826:Genetics, Medical / Q000187:drug effects*; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008708:Methemoglobinemia / Q000139:chemically induced; D008722:Methods; D010597:Pharmacogenetics; D010661:Phenylketonurias / Q000139:chemically induced; D011164:Porphyrias / Q000139:chemically induced; D011319:Primaquine / Q000009:adverse effects; D013390:Succinylcholine / Q000009:adverse effects; D014807:Vitamin D / Q000009:adverse effects
D002395:Catecholamines; D014807:Vitamin D; D013390:Succinylcholine; D011319:Primaquine; D007538:Isoniazid
Farmakogenetyka lekarska.